News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Valente Nancy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/03/2023 |
4
| Valente Nancy (EVP, Chief Development Officer) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 39,296 shares
@ $0
Granted 235,778 options
@ $27.07, valued at
$6.4M
|
|
| 03/10/2023 |
4
| Valente Nancy (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 36,892 options to buy
@ $22.71, valued at
$837.8k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| Valente Nancy (Director) has filed a Form 4 on Xencor Inc|
Txns:
| Granted 35,282 options to buy
@ $25.32, valued at
$893.3k
|
|
| 09/09/2022 |
3
| Valente Nancy (Director) has filed a Form 3 on Xencor Inc |
| 11/09/2021 |
4
| Valente Nancy (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 36,892 options to buy
@ $22.71, valued at
$837.8k
|
|
| 11/09/2021 |
3
| Valente Nancy (Director) has filed a Form 3 on Myovant Sciences Ltd. |
|
|